BeiGene, Ltd. (BGNE)
NASDAQ: BGNE · IEX Real-Time Price · USD
154.74
+2.71 (1.78%)
At close: Jul 19, 2024, 4:00 PM
154.75
+0.01 (0.01%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
BeiGene Market Cap
BeiGene has a market cap or net worth of $17.25 billion as of July 22, 2024. Its market cap has decreased by -13.07% in one year.
Market Cap
17.25B
Enterprise Value
15.52B
1-Year Change
-13.07%
Ranking
Category
Stock Price
$154.74
Market Cap Chart
Since February 3, 2016, BeiGene's market cap has increased from $861.90M to $17.25B, an increase of 1,901.95%. That is a compound annual growth rate of 42.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 16.18B | -14.20% |
| Dec 29, 2023 | 18.86B | -17.40% |
| Dec 30, 2022 | 22.83B | -10.17% |
| Dec 31, 2021 | 25.41B | 8.12% |
| Dec 31, 2020 | 23.50B | 133.90% |
| Dec 31, 2019 | 10.05B | 20.62% |
| Dec 31, 2018 | 8.33B | 87.56% |
| Dec 29, 2017 | 4.44B | 342.97% |
| Dec 30, 2016 | 1.00B | 16.34% |
| Feb 3, 2016 | 861.90M | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genmab | 18.08B |
| The Cooper Companies | 18.07B |
| Baxter International | 18.01B |
| Waters | 17.96B |
| Labcorp Holdings | 17.82B |
| Molina Healthcare | 16.90B |
| Quest Diagnostics | 16.22B |
| BioMarin Pharmaceutical | 15.97B |